Additional antibodies detected in the patients' blood included anti-Yo antibody in the patient with prostate cancer (case 4) and anti-AQP4 antibody and anti-Ro/SSA antibody in the patient with NMO and Sjögren syndrome (case 5) (Table 1). Here, CDR2 is linked to Sjogren syndrome.